Honisett, Suzy Y <br/><br/>
Hormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazone.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Sep 2004 
 - 4615-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jc.2003-031414  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Pressure<br/>Coronary Disease--etiology<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Double-Blind Method<br/>Endothelium, Vascular--drug effects<br/>Estradiol--administration & dosage<br/>Female<br/>Hormone Replacement Therapy--adverse effects<br/>Humans<br/>Lipids--blood<br/>Middle Aged<br/>Postmenopause<br/>Progesterone--administration & dosage<br/>Receptors, Cytoplasmic and Nuclear--metabolism<br/>Rosiglitazone<br/>Thiazolidinediones--therapeutic use<br/>Transcription Factors--metabolism